Related Experiment Video
Updated: Apr 6, 2026
09:37
Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information
Published on: August 15, 2019
10.6K
Genetic variation at the MECOM locus shaping human disease pathogenesis
Jiayi Chen1, Anirudh Venkatesh2, Kaifu Chen3
1Basic and Translational Research Division, Department of Cardiology, Boston Children's Hospital, Boston, MA 02115, USA; Department of Biomedical Informatics, Harvard Medical School, Boston, MA 02115, USA.
Pharmacology & Therapeutics
|April 5, 2026
Summary
The MECOM gene regulates development and its variants are linked to cancer, blood disorders, and cardiovascular diseases. Understanding MECOM variants is crucial for identifying disease mechanisms and potential therapeutic targets.
Area of Science:
- Genetics and Genomics
- Molecular Biology
- Human Disease Pathogenesis
Background:
- The MDS1 and EVI1 complex locus (MECOM) gene is a critical transcriptional regulator involved in development.
- MECOM variants are implicated in oncologic, hematopoietic, and increasingly, cardiovascular diseases.
Purpose of the Study:
- To comprehensively review the spectrum of MECOM variants and their association with human diseases.
- To integrate diverse genetic data to understand MECOM's role in disease mechanisms.
- To identify MECOM-associated SNPs as potential therapeutic targets.
Main Methods:
- Integration of genome-wide association studies (GWAS) and expression quantitative trait loci (eQTL) analyses.
- Analysis of curated databases and single-case reports from whole-exome (WES) and whole-genome sequencing (WGS).
- Review of common and rare MECOM variants.
Main Results:
- Identified a broad spectrum of MECOM variants linked to various human diseases.
- Demonstrated how specific MECOM alterations contribute to pathogenic mechanisms.
- Highlighted the genetic landscape of MECOM, encompassing both common and rare variants.
Conclusions:
- MECOM variants are significant drivers of oncologic, hematopoietic, and cardiovascular pathologies.
- Further investigation of MECOM-associated single-nucleotide polymorphisms (SNPs) is warranted for mechanistic and therapeutic insights.
- Targeting MECOM presents a potential strategy for disease intervention.
Related Concept Videos
01:20Mismatch Repair
7.1K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
7.1K
01:36Mismatch Repair
45.6K
Overview
45.6K
01:43Incomplete Dominance
32.6K
Gregor Mendel's work (1822 - 1884) was primarily focused on pea plants. Through his initial experiments, he determined that every gene in a diploid cell has two variants called alleles inherited from each parent. He suggested that amongst these two alleles, one allele is dominant in character and the other recessive. The combination of alleles determines the phenotype of a gene in an organism.
32.6K
01:27Principles of Pharmacogenetics: Types of Genetic Variants
98
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
98
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
114
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
114
01:29Pharmacogenomics: Identification of New Drug Targets
86
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
86